Key facts
- This page summarizes Jacqueline Studer's Form 4 filing for Akili, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Nov 2022, 18:55.
Jacqueline Studer - 02 Nov 2022 Form 4 Insider Report for Akili, Inc.
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- N/A
- Reported as of
- 02 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Nov 2022, 18:55:18 UTC
- Prior SEC filing
- 13 Dec 2022
- Next SEC filing
- 14 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jacqueline Studer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jacqueline Studer filed Form 4 for Akili, Inc. on 04 Nov 2022.
Change
- Previous filing in this sequence was filed on 13 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKLI
transaction
Common Stock
Award
- Transaction value
- Shares
- +37,612
- Change %
- Price
- Shares after
- 37,612
- Date
- 02 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
AKLI
transaction
Common Stock
Award
- Transaction value
- Shares
- +284,650
- Change %
- +757%
- Price
- Shares after
- 322,262
- Date
- 02 Nov 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AKLI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +152,729
- Change %
- Price
- $0.000000
- Shares after
- 152,729
- Date
- 02 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 152,729
- Exercise price
- $2.30
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents a grant of restricted stock units ("RSUs") under the Akili, Inc. 2022 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 16.67% of the RSUs underlying this grant shall vest on May 2, 2023, with an additional 16.67% vesting at the end of each six (6) month period thereafter, subject to the reporting person's continued service on each such vesting date.
Footnote F2
Represents a grant of RSUs under the Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs underlying this grant shall vest upon the Issuer's common stock achieving certain specified prices per share, subject to the reporting person's continued service at such time.
Footnote F3
16.67% of the shares underlying this option shall vest and become exercisable on May 2, 2023, with an additional 16.67% vesting at the end of each six (6) month period thereafter, subject to the reporting person's continued service on each such vesting date.